Integrated genomic characterization of pancreatic ductal adenocarcinoma

BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh… - Cancer cell, 2017 - cell.com
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic
ductal adenocarcinoma (PDAC) specimens, including samples with characteristic low
neoplastic cellularity. Deep whole-exome sequencing revealed recurrent somatic mutations
in KRAS, TP53, CDKN2A, SMAD4, RNF43, ARID1A, TGFβR2, GNAS, RREB1, and PBRM1.
KRAS wild-type tumors harbored alterations in other oncogenic drivers, including GNAS,
BRAF, CTNNB1, and additional RAS pathway genes. A subset of tumors harbored multiple …

Integrated genomic characterization of pancreatic ductal adenocarcinoma

Cancer Genome Atlas Research Network - Cancer cell, 2017 - pmc.ncbi.nlm.nih.gov
We performed integrated genomic, transcriptomic and proteomic profiling of 150 pancreatic
ductal adenocarcinoma (PDAC) specimens, including samples with characteristic low
neoplastic cellularity. Deep whole-exome sequencing revealed recurrent somatic mutations
in KRAS, TP53, CDKN2A, SMAD4, RNF43, ARID1A, TGFβR2, GNAS, RREB1 and PBRM1.
KRAS wild-type tumors harbored alterations in other oncogenic drivers, including GNAS,
BRAF, CTNNB1 and additional RAS pathway genes. A subset of tumors harbored multiple …